(Q46792339)

25 December 2017

title

Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis (English)

1 reference

25 December 2017

cost-effectiveness analysis

0 references

1 reference

1 reference

Shane Murphy

2

0 references

author name string

Stéphane Verguet

1

1 reference

25 December 2017

Benjamin Anderson

3

1 reference

25 December 2017

Kjell Arne Johansson

4

1 reference

25 December 2017

Roger Glass

5

1 reference

25 December 2017

Richard Rheingans

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

16 July 2013

1 reference

25 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

42

1 reference

25 December 2017

page(s)

4902-4910

1 reference

25 December 2017

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Burden and Epidemiology of Rotavirus Diarrhea in Selected African Countries: Preliminary Results from the African Rotavirus Surveillance Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Epidemiology and prospects for prevention of rotavirus disease in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Oral rotavirus vaccines: how well will they work where they are needed most?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Rotavirus: realising the potential of a promising vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Health and economic impact of rotavirus vaccination in GAVI-eligible countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Projected cost-effectiveness of rotavirus vaccination for children in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Economic evaluations of rotavirus immunization for developing countries: a review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Measles vaccination improves the equity of health outcomes: evidence from Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Protective effect of natural rotavirus infection in an Indian birth cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Global Illness and Deaths Caused by Rotavirus Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Incorporating financial protection into decision rules for publicly financed healthcare treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Risk Aversion in the Small and in the Large

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Borrowing and selling to pay for health care in low- and middle-income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

The Economic Lives of the Poor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

Disease and economic burden of rotavirus diarrhoea in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.07.014

1 reference

25 December 2017

1 reference

25 December 2017